表紙
市場調查報告書
商品編碼
871457

失禁用產品及造口術市場 - 成長,趨勢,及預測(2019年 - 2024年)

Incontinence Devices and Ostomy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球失禁用產品及造口術市場在2019年∼2024年間,預測將以10.1%的年複合成長率成長。市場成長要素,有老年人和肥胖者的增加,腎臟疾病和腎臟障礙的盛行率增加,造口術照護產品的接收等。

本報告提供全球失禁用產品及造口術市場的相關調查,市場概況和成長要素、阻礙因素,各產品類型、用途、地區的市場分析,競爭情形,主要企業的簡介等資訊彙整。

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 老年人口及肥胖人口的增加
    • 腎臟病及腎臟障礙的罹患率增加
    • 造口術照護產品相關的意識高漲與接受
  • 市場阻礙因素
    • 缺乏適當的償付
    • 造口術和失禁用產品的使用伴隨的併發症
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 產品的種類
    • 失禁護理產品
    • 造口術照護產品
  • 用途
    • 膀胱癌
    • 大腸癌症
    • 克隆氏症
    • 腎臟結石
    • 慢性腎衰竭
    • 其他的用途
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abena AS
    • B. Braun Melsungen AG
    • Coloplast Corporation
    • ConvaTec
    • Hollister Inc.
    • Kimberly-Clark Corporation
    • Salts Healthcare
    • SCA (Svenska Cellulosa Aktiebolaget)
    • Unicharm Corporation

第7章 市場機會及今後趨勢

目錄
Product Code: 57125

The incontinence devices and ostomy market is expected to register a CAGR of nearly 10.1%, during the forecast period. Certain factors that are driving the market growth include the rising geriatric and obese populations, increasing prevalence of renal diseases and nephrological injuries, and growing awareness and acceptance regarding ostomy care products. Adult diapers are significantly necessary in cases that involve mobility impairment, severe diarrhoea, or dementia. Decreased renal function, primarily age-related, is one of the major indicators of chronic diseases. This may be accelerated, due to several other chronic diseases, such as hypertension, diabetes, and obesity, among other diseases, often leading to different stages of kidney diseases. These diseases are health burdens, globally, with high economic costs to healthcare systems. As per the WHO's Integrated Care for Older People (ICOPE) Guidelines and specific population-based studies released in 2017, the global prevalence of UI was observed to be in the range of 8.9%-36.1%, in different patient pools.

Key Market Trends

Colorectal Cancer is Expected to Observe Lucrative Growth in the Application Segment

  • Colorectal cancer has one of the highest incidence rates and prevalence rates of all cancers, worldwide. The primary causes of colorectal cancer are found to be lifestyle disorders, ageing, and diet.
  • According to the American Institute for Cancer Research, over 1.8 million new cases of colorectal cancer were registered in 2018, globally. Colorectal cancer is a leading cause of both temporary and permanent ileostomy and colostomy procedures.
  • Therefore, the increasing prevalence of colorectal cancer is boosting ostomy procedures and creating new opportunities for manufacturers of ostomy products.

North America Dominates the Market, and is Expected to do the Same in the Forecast Period

  • Incontinence is a prevalent health condition, with a significant proportion of the population suffering from Crohn's Disease. However, it is rarely discussed, as in most of the cases, people are embarrassed to do so.
  • According to the National Association for Incontinence, more than 25 million people in the United States experience bladder leakage every day. Urinary incontinence is primarily associated with ageing, affecting up to 30% of elderly people. It occurs in 85% of long-term care patients and is often the reason for admission to these facilities.
  • Several companies, such as Kimberly-Clark and Svenska Cellulosa Aktiebolaget (SCA) among others, have a strong retail presence across the region, which is useful for adults living at-home care, hospitals, and institutions.

Competitive Landscape

The incontinence devices and ostomy market is highly competitive and consists of a number of major players. Companies, like Abena AS, B. Braun Melsungen AG, Coloplast Corporation, ConvaTec, Hollister Inc., Kimberly-Clark Corporation, Salts Healthcare, SCA (Svenska Cellulosa Aktiebolaget), and Unicharm Corporation, among others, hold substantial shares in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric and Obese Populations
    • 4.2.2 Increasing Prevalence of Renal Diseases and Nephrological Injuries
    • 4.2.3 Growing Awareness and Acceptance regarding Ostomy Care Products
  • 4.3 Market Restraints
    • 4.3.1 Lack of Proper Reimbursement
    • 4.3.2 Complications Associated with Ostomy and Usage of Incontinence Products
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product Type
    • 5.1.1 Incontinence Care Products
      • 5.1.1.1 Absorbents
      • 5.1.1.2 Incontinence Bags
      • 5.1.1.3 Other Product Types (Clamps, Deodorizers, Cleaners, Urinals, etc.)
    • 5.1.2 Ostomy Care Products
      • 5.1.2.1 Ostomy Bags
      • 5.1.2.1.1 Colostomy Bags
      • 5.1.2.1.2 Ileostomy Bags
      • 5.1.2.1.3 Urostomy Bags
      • 5.1.2.2 Skin Barriers
      • 5.1.2.3 Irrigation Products
      • 5.1.2.4 Other Ostomy Products
  • 5.2 Application
    • 5.2.1 Bladder Cancer
    • 5.2.2 Colorectal Cancer
    • 5.2.3 Crohn's Disease
    • 5.2.4 Kidney Stone
    • 5.2.5 Chronic Kidney Failure
    • 5.2.6 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abena AS
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Coloplast Corporation
    • 6.1.4 ConvaTec
    • 6.1.5 Hollister Inc.
    • 6.1.6 Kimberly-Clark Corporation
    • 6.1.7 Salts Healthcare
    • 6.1.8 Unicharm Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS